Adrian De Froment

Adrian has a broad commercial chancery practice, with a particular focus on commercial disputes, intellectual property, offshore disputes and civil fraud. Much of Adrian's work also has an international or cross-border element to it, and he has experience of jurisdiction disputes, conflict of laws, service out of the jurisdiction, enforcement of foreign judgments and interim relief including freezing relief.

Adrian regularly appears in the High Court and IPEC, including recently acting unled for the successful parties in two patent disputes (D.W. Windsor Limited v Urbis Schreder Limited [2025] EWHC 563 (IPEC) and Bionome Technology Limited v Clearwater [2024] EWHC 3155 (Ch)), and, led by Michael Edenborough KC, for the defendants in a high-value trade mark dispute: iMiracle (HK) Limited v Vapes-Bars Limited [2023] EWHC 2972. He also represented the defendants in INVISTA v Botes and ors [2019] EWHC 58 (Ch), a 7-day trial before Birss J. of claims relating to alleged breaches of confidence by research scientists.

Prior to coming to the Bar, Adrian gained a PhD in evolutionary biology from Princeton University and as a former scientist he is well placed to deal with scientific and quantitative issues that arise in litigation.